英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
uninebriatedness查看　uninebriatedness　在百度字典中的解释百度英翻中〔查看〕
uninebriatedness查看　uninebriatedness　在Google字典中的解释Google英翻中〔查看〕
uninebriatedness查看　uninebriatedness　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Ingrezza Dosage Guide - Drugs. com
    A dosage of 40 mg or 60 mg once daily may be considered depending on response and tolerability Chorea Associated with Huntington ’s Disease The initial dosage for INGREZZA and INGREZZA SPRINKLE is 40 mg once daily Increase the dose in 20 mg increments every two weeks to the recommended dosage of 80 mg once daily
  • MEDICATION GUIDE INGREZZA (in greh zah) INGREZZA SPRINKLE (in . . .
    • Store INGREZZA between 59°F to 86°F (15°C to 30°C) • Store INGREZZA SPRINKLE between 68°F to 77°F (20°C to 25°C) • Keep the bottle tightly closed to protect INGREZZA SPRINKLE from moisture • INGREZZA SPRINKLE granules added to soft food can be stored for up to 2 hours at room temperature between 68°F to 77°F (20°C to 25°C)
  • INGREZZA. INGREZZA -------------------------------ADVERSE . . .
    Consider reducing INGREZZA dose based on tolerability when INGREZZA is coadministered with a strong CYP2D6 inhibitor [see Drug Interactions (7 1)] 3 DOSAGE FORMS AND STRENGTHS INGREZZA capsules are available in the following strengths: • 40 mg capsules with a white opaque body and purple cap, printed with ‘VBZ’ and ‘40’ in black ink
  • Ingrezza Dosage: Form, Strengths, How to Use, and More
    Get important Ingrezza dosage information in plain English Learn about the drug’s dosing, form, strengths, and more Ingrezza is prescribed to treat tardive dyskinesia and other movement disorders
  • Ingrezza (Valbenazine Capsules): Side Effects, Uses, Dosage . . .
    The safety of INGREZZA was evaluated in 3 placebo-controlled studies, each 6 weeks in duration (fixed dose, dose escalation, dose reduction), including 445 patients Patients were 26 to 84 years of age with moderate to severe tardive dyskinesia and had concurrent diagnoses of mood disorder (27%) or schizophrenia schizoaffective disorder (72%)





中文字典-英文字典  2005-2009